Senior Director - West International Cluster, Global Rare BU at Alnylampharmaceuticals, Zug

Senior Director - West International Cluster, Global Rare BU at Alnylampharmaceuticals in Zug. Apply with swipeandhired.

Snr Director West International Cluster, Global Rare BU - Closing Date: November 13, 2027.

This role will be responsible to develop and execute all sales and marketing activities in the relative cluster of countries, with immediate focus on driving the development of GIVLAARI and OXLUMO.

This person will:

The role will lead a team of Field Business Leaders (FBL) across a group of geographies and be the primary interface with local Country Managers and International TTR BU shared services (eg Regional Commercial, Business Operations and and Market Access). They will appropriately partner with Medical and Regional Marketing to ensure optimal alignment, insight sharing and communication. The Cluster Head will also build and execute the Cluster tactical plan (e.g.,Sales force and HCP target group prioritization, congress activities, marketing materials) and participate in the regional tactics as appropriate (e.g., European congresses).

The Cluster Head reports to the VP, International Rare Head.

Summary of Key Responsibilities

Manages the full Commercial Team for the specific geographies (Field Business Leaders and their KAMs)

Qualifications, Key Skills, and Competencies

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

#LI-CC1 #LI-Hybrid
Find more English Speaking Jobs in Switzerland on Arbeitnow